CABA as of Nov 3 · 18:55 ET
CABANasdaqBiological Products, (No Diagnostic Substances)

Cabaletta Bio, Inc. · Brief

Next report

6 days

Nov 9 · before openest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±12.6%▼−4.91%×0.39
quarterimplied−15%0+15%realized×
Q2 FY26±12.6%▼−4.91%×0.39
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2 of 3

14disclosed supplier and customer ties in SEC filingsSEC filings
142managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

4tracked funds holding CABAN-PORT · Aug 31 '26
0.15%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

CABA report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 27impliedImplied move: ±32.1% into Nov 9 earnings (Oct 27 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.